{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:13:15Z","timestamp":1792789995242,"version":"4.5.0"},"reference-count":44,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Key R &amp; D project in Shandong Province","award":["2017CXGC1309"],"award-info":[{"award-number":["2017CXGC1309"]}]},{"name":"he Key Research and Technology demonstration and industrialization of TCM prescription of the Science and Technology Department of Shandong Province","award":["2016CYJS08A01-8"],"award-info":[{"award-number":["2016CYJS08A01-8"]}]},{"name":"Key Research and Development Projects of Science and Technology Department of Shandong Province","award":["2016GSF202040"],"award-info":[{"award-number":["2016GSF202040"]}]},{"name":"Shandong Province Medical and Health Technology Development Project","award":["2016WSB22003"],"award-info":[{"award-number":["2016WSB22003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Ebola virus is the causative agent of Ebola virus disease in humans. The lethality of Ebola virus infection is about 50%, supporting the urgent need to develop anti-Ebola drugs. Glycoprotein (GP) is the only surface protein of the Ebola virus, which is functionally critical for the virus to attach and enter the host cells, and is a promising target for anti-Ebola virus drug development. In this study, using the recombinant HIV-1\/Ebola pseudovirus platform we previously established, we evaluated a small molecule library containing various quinoline compounds for anti-Ebola virus entry inhibitors. Some of the quinoline compounds specifically inhibited the entry of the Ebola virus. Among them, compound SYL1712 was the most potent Ebola virus entry inhibitor with an IC50 of ~1 \u03bcM. The binding of SYL1712 to the vial glycoprotein was computationally modeled and was predicted to interact with specific residues of GP. We used the time of the addition assay to show that compound SYL1712 blocks Ebola GP-mediated entry. Finally, consistent with being an Ebola virus entry inhibitor, compound SYL1712 inhibited infectious Ebola virus replication in tissue culture under biosafety level 4 containment, with an IC50 of 2 \u03bcM. In conclusion, we identified several related molecules with a diaryl-quinoline scaffold as potential anti-EBOV entry inhibitors, which can be further optimized for anti-Ebola drug development.<\/jats:p>","DOI":"10.3390\/v10120678","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T12:13:17Z","timestamp":1543579997000},"page":"678","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus"],"prefix":"10.3390","volume":"10","author":[{"given":"Qinghua","family":"Cui","sequence":"first","affiliation":[{"name":"College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China"},{"name":"Department of Microbiology and Immunology, College of Medicine, The University of Illinois at Chicago, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, College of Medicine, The University of Illinois at Chicago, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, and UICentre, University of Illinois at Chicago, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0774-5710","authenticated-orcid":false,"given":"Gang","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bioactive Substances and Function of Natural Medicine, Institute of Materia Medica, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100050, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruikun","family":"Du","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Anantpadma","sequence":"additional","affiliation":[{"name":"Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX 78227, USA"},{"name":"Department of Microbiology, Boston University, National Emerging Infectious Diseases Laboratories, 401P, 620 Albany Street, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Davey","sequence":"additional","affiliation":[{"name":"Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX 78227, USA"},{"name":"Department of Microbiology, Boston University, National Emerging Infectious Diseases Laboratories, 401P, 620 Albany Street, Boston, MA 02118, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Rong","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, College of Medicine, The University of Illinois at Chicago, Chicago, IL 60612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00705-010-0814-x","article-title":"Proposal for a revised taxonomy of the family filoviridae: Classification, names of taxa and viruses, and virus abbreviations","volume":"155","author":"Kuhn","year":"2010","journal-title":"Arch. Virol."},{"key":"ref_2","unstructured":"World Health Organization (WHO) (2018, May 10). Ebola Virus Disease\u2014Democratic Republic of the Congo. Available online: http:\/\/www.Who.Int\/csr\/don\/23-may-2018-ebola-drc\/en\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature13777","article-title":"Reversion of advanced Ebola virus disease in nonhuman primates with ZMAPP","volume":"514","author":"Qiu","year":"2014","journal-title":"Nature"},{"key":"ref_4","unstructured":"Walldorf, J.A., Cloessner, E.A., Hyde, T.B., MacNeil, A., and CDC Emergency Ebola Vaccine Taskforce (2017). Considerations for use of Ebola vaccine during an emergency response. Vaccine."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule gs-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.jmb.2014.01.010","article-title":"In silico derived small molecules bind the filovirus vp35 protein and inhibit its polymerase cofactor activity","volume":"426","author":"Brown","year":"2014","journal-title":"J. Mol. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.2174\/0929867324666171010141416","article-title":"Development of potential small molecule therapeutics for treatment of Ebola virus","volume":"25","author":"Schafer","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Cui, Q., Du, R., Anantpadma, M., Schafer, A., Hou, L., Tian, J., Davey, R.A., Cheng, H., and Rong, L. (2018). Identification of ellagic acid from plant Rhodiola rosea l. As an anti-Ebola virus entry inhibitor. Viruses, 10.","DOI":"10.3390\/v10040152"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1126\/science.1258758","article-title":"Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment","volume":"347","author":"Sakurai","year":"2015","journal-title":"Science"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal niemann-pick c1 is essential for Ebola virus infection","volume":"477","author":"Cote","year":"2011","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/emi.2013.77","article-title":"Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents","volume":"2","author":"Chang","year":"2013","journal-title":"Emerg. Microbes Infect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1128\/JVI.01160-10","article-title":"Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway","volume":"85","author":"Fabozzi","year":"2011","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.2202","article-title":"Advanced antisense therapies for postexposure protection against lethal filovirus infections","volume":"16","author":"Warren","year":"2010","journal-title":"Nat. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1128\/JVI.79.8.4793-4805.2005","article-title":"Comprehensive analysis of Ebola virus gp1 in viral entry","volume":"79","author":"Manicassamy","year":"2005","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S251","DOI":"10.1086\/520597","article-title":"Analysis of filovirus entry into vero E6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity","volume":"196","author":"Sanchez","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10982","DOI":"10.1128\/JVI.01490-15","article-title":"Mechanism of binding to Ebola virus glycoprotein by the zmapp, zmab, and mb-003 cocktail antibodies","volume":"89","author":"Davidson","year":"2015","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"18030","DOI":"10.1073\/pnas.1213709109","article-title":"Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques","volume":"109","author":"Olinger","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1093\/infdis\/jiv223","article-title":"Novel small molecule entry inhibitors of Ebola virus","volume":"212","author":"Basu","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1128\/JVI.01456-10","article-title":"Identification of a small-molecule entry inhibitor for filoviruses","volume":"85","author":"Basu","year":"2011","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/jm1008715","article-title":"Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry","volume":"54","author":"Yermolina","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cmdc.201600441","article-title":"Structural simplification of bedaquiline: The discovery of 3-(4-(N,N-dimethylaminomethyl)phenyl)quinoline-derived antitubercular lead compounds","volume":"12","author":"He","year":"2017","journal-title":"ChemMedChem"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1743-422X-6-39","article-title":"Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza","volume":"6","author":"Guo","year":"2009","journal-title":"Virol. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature05539","article-title":"Transferrin receptor 1 is a cellular receptor for new world haemorrhagic fever arenaviruses","volume":"446","author":"Radoshitzky","year":"2007","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1128\/jvi.69.11.6705-6711.1995","article-title":"Human-immunodeficiency-virus type-1 viral-protein-r (VPR) arrests cells in the G(2) phase of the cell-cycle by inhibiting p34(CDC2) activity","volume":"69","author":"He","year":"1995","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.antiviral.2018.07.003","article-title":"Repurposing potential of 1st generation h1-specific antihistamines as anti-filovirus therapeutics","volume":"157","author":"Schafer","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/AAC.00543-16","article-title":"Large-scale screening and identification of novel Ebola virus and marburg virus entry inhibitors","volume":"60","author":"Anantpadma","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1086\/520590","article-title":"In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein","volume":"196","author":"Ebihara","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2006.08.018","article-title":"Release of cellular proteases into the acidic extracellular milieu exacerbates Ebola virus-induced cell damage","volume":"358","author":"Barrientos","year":"2007","journal-title":"Virology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/mol.110.064261","article-title":"A small-molecule oxocarbazate inhibitor of human cathepsin l blocks severe acute respiratory syndrome and Ebola pseudotype virus infection into human embryonic kidney 293T cells","volume":"78","author":"Shah","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/med.21466","article-title":"Biologically active quinoline and quinazoline alkaloids part I","volume":"38","author":"Shang","year":"2018","journal-title":"Med. Res. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1087057113494405","article-title":"A comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses","volume":"19","author":"Wang","year":"2014","journal-title":"J. Biomol. Screen."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1021\/acs.jmedchem.7b01249","article-title":"Target identification and mode of action of four chemically divergent drugs against Ebola virus infection","volume":"61","author":"Ren","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1128\/JVI.01337-15","article-title":"Inhibition of Ebola and Marburg virus entry by G protein-coupled receptor antagonists","volume":"89","author":"Cheng","year":"2015","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature18615","article-title":"Toremifene interacts with and destabilizes the Ebola virus glycoprotein","volume":"535","author":"Zhao","year":"2016","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1021\/acs.jmedchem.8b00350","article-title":"Structures of ebola virus glycoprotein complexes with tricyclic antidepressant and antipsychotic drugs","volume":"61","author":"Zhao","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"13378","DOI":"10.1128\/JVI.01170-07","article-title":"Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity","volume":"81","author":"Kaletsky","year":"2007","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.virol.2011.11.031","article-title":"Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of tmprss2 expression","volume":"424","author":"Gnirss","year":"2012","journal-title":"Virology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/acsinfecdis.5b00130","article-title":"Cysteine cathepsin inhibitors as anti-Ebola agents","volume":"2","author":"Schulze","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/id500025n","article-title":"Chemical and structural aspects of Ebola virus entry inhibitors","volume":"1","author":"Nyakatura","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.antiviral.2015.01.011","article-title":"Protease inhibitors targeting coronavirus and filovirus entry","volume":"116","author":"Zhou","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e12177","DOI":"10.7554\/eLife.12177","article-title":"Identification of npc1 as the target of u18666a, an inhibitor of lysosomal cholesterol export and ebola infection","volume":"4","author":"Lu","year":"2015","journal-title":"eLife"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"190ra79","DOI":"10.1126\/scitranslmed.3005471","article-title":"FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection","volume":"5","author":"Johansen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.antiviral.2017.06.015","article-title":"Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor","volume":"145","author":"Cheng","year":"2017","journal-title":"Antivir. Res."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/12\/678\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:33:32Z","timestamp":1760196812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/12\/678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["v10120678"],"URL":"https:\/\/doi.org\/10.3390\/v10120678","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]}}}